These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11555586)

  • 1. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
    Ghadersohi A; Sood AK
    Clin Cancer Res; 2001 Sep; 7(9):2731-8. PubMed ID: 11555586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.
    Ghadersohi A; Odunsi K; Lele S; Collins Y; Greco WR; Winston J; Liang P; Sood AK
    Oncol Rep; 2004 Feb; 11(2):453-8. PubMed ID: 14719083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor associated antigen recognition by autologous serum in patients with breast cancer.
    Qian F; Odunsi K; Blatt LM; Scanlan MJ; Mannan M; Shah N; Montgomery J; Haddad F; Taylor M
    Int J Mol Med; 2005 Jan; 15(1):137-44. PubMed ID: 15583840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression.
    Feldman RJ; Sementchenko VI; Gayed M; Fraig MM; Watson DK
    Cancer Res; 2003 Aug; 63(15):4626-31. PubMed ID: 12907642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
    Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells.
    Thelen P; Jarry H; Ringert RH; Wuttke W
    Planta Med; 2004 May; 70(5):397-400. PubMed ID: 15124082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer.
    Sidiropoulos M; Chang A; Jung K; Diamandis EP
    Br J Cancer; 2001 Aug; 85(3):393-7. PubMed ID: 11487271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
    Steffan JJ; Koul HK
    Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library.
    Jäger D; Stockert E; Güre AO; Scanlan MJ; Karbach J; Jäger E; Knuth A; Old LJ; Chen YT
    Cancer Res; 2001 Mar; 61(5):2055-61. PubMed ID: 11280766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
    Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
    FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel prostate cancer-associated tumor antigen.
    Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC
    Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
    Fuessel S; Sickert D; Meye A; Klenk U; Schmidt U; Schmitz M; Rost AK; Weigle B; Kiessling A; Wirth MP
    Int J Oncol; 2003 Jul; 23(1):221-8. PubMed ID: 12792797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of expressed sequences that include a gene for familial breast cancer (BRCA2) and other novel transcripts from a five megabase region on chromosome 13q12.
    Jacob AN; Kandpal G; Kandpal RP
    Oncogene; 1996 Jul; 13(1):213-21. PubMed ID: 8700550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.
    Cho JY; Lee M; Ahn JM; Park ES; Cho JH; Lee SJ; Kim BG; Heo SH; Park HJ; Zerbini LF; Hwang D; Libermann TA
    J Proteome Res; 2009 Mar; 8(3):1327-37. PubMed ID: 19203193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer expression profiling by cDNA sequencing analysis.
    Huang GM; Ng WL; Farkas J; He L; Liang HA; Gordon D; Yu J; Hood L
    Genomics; 1999 Jul; 59(2):178-86. PubMed ID: 10409429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
    Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
    Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.